Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa

<strong>Background:</strong> Selecting the optimal combination of HIV drugs for an individual in resourcelimited settings is challenging because of the limited availability of drugs and genotyping. Objective: The evaluation as a potential treatment support tool of computational models th...

Full description

Bibliographic Details
Main Authors: Revell, A, Khabo, P, Ledwaba, L, Emery, S, Wang, D, Wood, R, Morrow, C, Tempelman, H, Hamers, RL, Reiss, P, Van Sighem, A, Pozniak, A, Montaner, J, Lane, HC, Larder, B
Format: Journal article
Language:English
Published: Health and Medical Publishing Group 2016
_version_ 1797082685068279808
author Revell, A
Khabo, P
Ledwaba, L
Emery, S
Wang, D
Wood, R
Morrow, C
Tempelman, H
Hamers, RL
Reiss, P
Van Sighem, A
Pozniak, A
Montaner, J
Lane, HC
Larder, B
author_facet Revell, A
Khabo, P
Ledwaba, L
Emery, S
Wang, D
Wood, R
Morrow, C
Tempelman, H
Hamers, RL
Reiss, P
Van Sighem, A
Pozniak, A
Montaner, J
Lane, HC
Larder, B
author_sort Revell, A
collection OXFORD
description <strong>Background:</strong> Selecting the optimal combination of HIV drugs for an individual in resourcelimited settings is challenging because of the limited availability of drugs and genotyping. Objective: The evaluation as a potential treatment support tool of computational models that predict response to therapy without a genotype, using cases from the Phidisa cohort in South Africa. <strong>Methods:</strong> Cases from Phidisa of treatment change following failure were identified that had the following data available: baseline CD4 count and viral load, details of failing and previous antiretroviral drugs, drugs in new regimen and time to follow-up. The HIV Resistance Response Database Initiative’s (RDI’s) models used these data to predict the probability of a viral load &lt; 50 copies/mL at follow-up. The models were also used to identify effective alternative combinations of three locally available drugs. <strong>Results:</strong> The models achieved accuracy (area under the receiver–operator characteristic curve) of 0.72 when predicting response to therapy, which is less accurate than for an independent global test set (0.80) but at least comparable to that of genotyping with rules-based interpretation. The models were able to identify alternative locally available three-drug regimens that were predicted to be effective in 69% of all cases and 62% of those whose new treatment failed in the clinic. <strong>Conclusion:</strong> The predictive accuracy of the models for these South African patients together with the results of previous studies suggest that the RDI’s models have the potential to optimise treatment selection and reduce virological failure in different patient populations, without the use of a genotype.
first_indexed 2024-03-07T01:31:16Z
format Journal article
id oxford-uuid:93aeb64d-1941-4428-99b1-45055cd3602c
institution University of Oxford
language English
last_indexed 2024-03-07T01:31:16Z
publishDate 2016
publisher Health and Medical Publishing Group
record_format dspace
spelling oxford-uuid:93aeb64d-1941-4428-99b1-45055cd3602c2022-03-26T23:34:03ZComputational models as predictors of HIV treatment outcomes for the Phidisa cohort in South AfricaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:93aeb64d-1941-4428-99b1-45055cd3602cEnglishSymplectic Elements at OxfordHealth and Medical Publishing Group2016Revell, AKhabo, PLedwaba, LEmery, SWang, DWood, RMorrow, CTempelman, HHamers, RLReiss, PVan Sighem, APozniak, AMontaner, JLane, HCLarder, B<strong>Background:</strong> Selecting the optimal combination of HIV drugs for an individual in resourcelimited settings is challenging because of the limited availability of drugs and genotyping. Objective: The evaluation as a potential treatment support tool of computational models that predict response to therapy without a genotype, using cases from the Phidisa cohort in South Africa. <strong>Methods:</strong> Cases from Phidisa of treatment change following failure were identified that had the following data available: baseline CD4 count and viral load, details of failing and previous antiretroviral drugs, drugs in new regimen and time to follow-up. The HIV Resistance Response Database Initiative’s (RDI’s) models used these data to predict the probability of a viral load &lt; 50 copies/mL at follow-up. The models were also used to identify effective alternative combinations of three locally available drugs. <strong>Results:</strong> The models achieved accuracy (area under the receiver–operator characteristic curve) of 0.72 when predicting response to therapy, which is less accurate than for an independent global test set (0.80) but at least comparable to that of genotyping with rules-based interpretation. The models were able to identify alternative locally available three-drug regimens that were predicted to be effective in 69% of all cases and 62% of those whose new treatment failed in the clinic. <strong>Conclusion:</strong> The predictive accuracy of the models for these South African patients together with the results of previous studies suggest that the RDI’s models have the potential to optimise treatment selection and reduce virological failure in different patient populations, without the use of a genotype.
spellingShingle Revell, A
Khabo, P
Ledwaba, L
Emery, S
Wang, D
Wood, R
Morrow, C
Tempelman, H
Hamers, RL
Reiss, P
Van Sighem, A
Pozniak, A
Montaner, J
Lane, HC
Larder, B
Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title_full Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title_fullStr Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title_full_unstemmed Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title_short Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa
title_sort computational models as predictors of hiv treatment outcomes for the phidisa cohort in south africa
work_keys_str_mv AT revella computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT khabop computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT ledwabal computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT emerys computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT wangd computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT woodr computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT morrowc computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT tempelmanh computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT hamersrl computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT reissp computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT vansighema computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT pozniaka computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT montanerj computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT lanehc computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica
AT larderb computationalmodelsaspredictorsofhivtreatmentoutcomesforthephidisacohortinsouthafrica